Tag

Vktx

All articles tagged with #vktx

finance1 year ago•2 min saved

"Analysts Laud Viking Therapeutics' Soaring Stock on Positive Weight-Loss Drug Data"

Viking Therapeutics stock surged by 25% after announcing positive results from a phase 1 clinical study of its oral obesity drug VK2735, showing up to 3.3% placebo-adjusted mean weight loss and promising safety and tolerability. The company plans to advance the oral and injectable formulations of the drug into further testing, with expectations for strong pipeline prospects, making it a potential buy for aggressive investors.

via Yahoo Finance|

#finance #obesity-drug #phase-1-clinical-study

finance1 year ago•2 min saved

"Viking Therapeutics' Weight-Loss Drug Challenges Industry Leaders"

Viking Therapeutics stock experienced a volatile week following the announcement of positive phase II clinical trial results for its weight-loss drug, VK2735, causing shares to more than double on Tuesday. Despite a subsequent 15% drop after a stock offering, the stock has seen a 322% increase since the beginning of the year. The drug's impressive weight-loss results have sparked Wall Street's interest, with analysts raising peak sales estimates and suggesting that Viking could be an acquisition target for big pharmaceutical companies.

via Yahoo Finance|

#clinical-trial-results #finance #stock-offering

pharmaceuticals1 year ago•2 min saved

"Viking Therapeutics' Breakthrough Weight-Loss Drug Challenges Pharma Giants"

Viking Therapeutics' latest weight loss drug trial showed greater efficacy compared to competitors Eli Lilly and Company and Novo Nordisk A/S, positioning the company as a potential acquisition target. The phase II trial demonstrated up to 15% body weight loss with comparable side effects, setting the stage for phase III trials to confirm the results. Despite potential competition from other candidates, the development presents an interesting opportunity in the pharmaceutical industry, particularly for companies like Lilly.

via Yahoo Finance|

#pharmaceutical-industry #pharmaceuticals #phase-iii-trials